The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors

American Journal of Pathology

Volumn 160, Issue 1, 2002, Pages 15-22

  Andersson, Johanna ^a   Sjögren, Helene ^a   Meis Kindblom, Jeanne M ^a   Stenman, Göran ^a   Åman, Pierre ^a   Kindblom, Lars Gunnar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 14; CHROMOSOME 1P; CHROMOSOME 22; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CLONE; EXON; FEMALE; GASTROINTESTINAL TUMOR; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HUMAN; KARYOTYPE; MALE; MALIGNANT NEOPLASTIC DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0036141147     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64343-X     Document Type: Article

References (52)

1. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
2. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors
3. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
4. Human protooncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand
5. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
6. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene
7. Identification of a ligand for the c-kit proto-oncogene
8. Requirement of c-kit for development of intestinal pacemaker system
9. Mutation of the protooncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine
10. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity
11. C-kit-dependent development of interstitial cells and electrical activity in the murine gastrointestinal tract
12. Interstitial cells of Cajal generate electrical slow waves in the murine stomach
13. Cellular and molecular basis for electrical rhythmicity in gastrointestinal muscles
14. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors
15. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene
16. Molecular pathology of c-kit protooncogene and development of gastrointestinal stromal tumors
17. Familial gastrointestinal stromal tumor with hyperpigmentation: Association with a germline mutation of the c-kit gene
18. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
19. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas
20. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors
21. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
22. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal)
23. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor
24. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
25. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors: A study of 200 cases
26. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours
27. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors
28. Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase
29. Alternate splicing creates two forms of the human kit protein
30. Expression of the Kit and KitA receptor isoforms in human acute myelogenous leukemia
31. Activating c-kit gene mutations in human germ cell tumors
32. Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts
33. Cytogenetic observations in a human gastric leiomyosarcoma
34. Recurrent chromosome aberrations in abdominal smooth muscle tumors
35. Chromosomal abnormalities in leiomyosarcomas
36. Two cases of low-grade gastric leiomyosarcoma with monosomy 14 as the only change
37. Gastrointestinal stromal tumor, uncommitted type, with monosomies 14 and 22 as the only chromosomal abnormalities
38. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors)
39. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21)
40. Multicolor spectral karyotyping of human chromosomes
41. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis
42. The Steel/W transduction pathway: Kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor
43. Phosphatidylinositol 3′-kinase associates with p145c-kit as part of a cell type characteristic multimeric signalling complex
44. Kit signal transduction
45. Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors
46. Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors
47. High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci
48. DNA sequence copy number changes in gastrointestinal stromal tumors: Tumor progression and prognostic significance
49. Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors
50. Effect of the tyrosine kinase inhibitor ST1571 in a patient with a metastatic gastrointestinal stromal tumor
51. Abl protein-tyrosine kinase inhibitor ST1571 inhibits in vitro signal transcluction mediated by c-Kit and platelet-derived growth factor receptors